Prognostic impact of blood transfusion in patients undergoing primary surgery and free-flap reconstruction for oral squamous cell carcinoma

Cancer

Volumn 115, Issue 7, 2009, Pages 1481-1488

  Fenner, Matthias ^a   Vairaktaris, Eleftherios ^b   Nkenke, Emeka ^a   Weisbach, Volker ^a   Neukam, Friedrich W ^a   Radespiel Tröger, Martin ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Population Based Cancer Registry Bavaria   (Germany)

Author keywords

Oral squamous cell carcinoma; Prognosis; Survival; Transfusion

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; FEMALE; FREE TISSUE GRAFT; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE RECONSTRUCTION; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

BLOOD TRANSFUSION; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL FLAPS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 63449125405     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24132     Document Type: Article

References (27)

1. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253-259.
2. Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care. 2004;8:S18-S23.
3. Williams JG, Hughes LE. Effect of perioperative blood transfusion on recurrence of Crohn's disease. Lancet. 1989;2:131-133.
4. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer [serial online]. Cochrane Database Syst Rev. 2002;1:CD005033.
5. von Doersten P, Cruz RM, Selby JV, Hilsinger RL Jr. Transfusion, recurrence, and infection in head and neck cancer surgery. Otolaryngol Head Neck Surg. 1992;106:60- 67.
6. Jackson RM, Rice DH. Blood transfusions and recurrence in head and neck cancer. Ann Otol Rhinol Laryngol. 1998; 98:171-173.
7. Szakmany T, Dodd M, Dempsey GA, et al. The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma. Br J Cancer. 2006;94:647-653.
8. Taniguchi Y, Okura M. Prognostic significance of perioper- ative blood transfusion in oral cavity squamous cell carcinoma. Head Neck. 2003;25:931-936.
9. Woolley AL, Hogikyan ND, Gates GA, Haughey BH, Schechtman KB, Goldenberg JL. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Ann Otol Rhinol Laryngol. 1992;101:724-730.
10. Weber RS. A model for predicting transfusion requirements in head and neck surgery. Laryngoscope. 1995;105(suppl):1-17.
11. Holsinger FC, Weber RS. Swing of the surgical pendulum: a return to surgery for treatment of head and neck cancer in the 21st century? Int J Radiat Oncol Biol Phys. 2007;69(suppl):S129-S131.
12. American Society of Anesthesiologists Task Force on Prea- nesthesia Evaluation. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology. 2002;96:485-496.
13. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors, 6th ed. New York: John Wiley & Sons, Inc.; 2002.
14. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002;359:1309-1310.
15. Abrahamowicz M, Mackenzie T, Esdaile JM. Time-dependent hazard ratio: modelling and hypothesis testing with application in lupus nephritis. J Am Stat Assoc. 1996;91:1432-1439.
16. Hess KR. Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions. Stat Med. 1994;13:1045-1062.
17. Orbe J, Ferreira E, Nunez-Anton V. Comparing proportional hazards and accelerated failure time models for survival analysis. Stat Med. 2002;21:3493-3510.
18. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1985;72:511-518.
19. McCulloch TM, Glenn MG, Riley D, Weymuller EA. Blood use in head and neck tumor surgery. Potential for autologous blood. Arch Otolaryngol Head Neck Surg. 1989;115:1314-1317.
20. Skoner JM, Wax MK. Microvascular free-tissue transfer for head and neck reconstruction in Jehovah's Witness patients. Head Neck. 2008;30:455-460.
21. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91:2214-2221.
22. Weber RS, Jabbour N, Martin RC 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol. 2008;15:34-45.
23. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-417.
24. Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogenic blood transfusion. Transfusion. 2003;43:668-676.
25. Reid BC, Alberg AJ, Klassen AC, Koch WM, Samet JM. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck. 2001;23:985-994.
26. Kendal WS. Dying with cancer: the influence of age, comorbidity, and cancer site. Cancer. 2008;112:1354-1362.
27. Konski A, Berkey BA, Kian Ang K, Fu KK. Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03. Cancer. 2003; 98:1497-1503.